Evidence map›Paper›PMID 31372889›Full record

ArticleSurgical endoscopy2019

Assessment of the aerosol distribution pattern of a single-port device for intraperitoneal administration of therapeutic substances.

Rafael Seitenfus, Antonio Nocchi Kalil, Eduardo Dipp de Barros, Claudio Galeano Zettler, Gabriel Oliveira Dos Santos, Olivier Glehen, Carlos Humberto Cereser Junior, Paulo Roberto Walter Ferreira

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Rafael SeitenfusSurgical Oncology Service, Hospital Santa Rita, Santa Casa de Misericórdia, Porto Alegre, RS, Brazil. rafasei@hotmail.com.ORCID 0000-0001-8481-2759
Antonio Nocchi KalilSurgical Oncology Service, Hospital Santa Rita, Santa Casa de Misericórdia, Porto Alegre, RS, Brazil.
Eduardo Dipp de BarrosSurgical Oncology Service, Hospital Santa Rita, Santa Casa de Misericórdia, Porto Alegre, RS, Brazil.
Claudio Galeano ZettlerPathology and Cytology Service, Hospital Santa Rita, Santa Casa de Misericórdia, Porto Alegre, RS, Brazil.
Gabriel Oliveira Dos SantosPathology and Cytology Service, Hospital Santa Rita, Santa Casa de Misericórdia, Porto Alegre, RS, Brazil.
Olivier GlehenDepartment of Surgical Oncology, Centre Hospitalier Lyon-Sud, Hospices Civils De Lyon, Pierre-Benite, France.
Carlos Humberto Cereser JuniorSurgical Oncology Service, Hospital Santa Rita, Santa Casa de Misericórdia, Porto Alegre, RS, Brazil.
Paulo Roberto Walter FerreiraGraduate Program in Engineering, Innovation and Entrepreneurship, Faculdade de Desenvolvimento do Rio Grande do Sul (FADERGS), Porto Alegre, RS, Brazil.
Santa Casa Hospital · BRFaculdade de Desenvolvimento do Rio Grande do Sul · BRHôpital Lyon Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the last 20 years, intraperitoneal chemotherapy (IPC) has been explored as a modality for the management of peritoneal metastases of gynecologic, gastrointestinal, and primary peritoneal tumors. Direct delivery of chemotherapeutic agents to the peritoneal cavity space has proved superior to systemic chemotherapy when evaluating characteristics such as drug concentration reached in the peritoneal space, penetration into peritoneal metastases, and chemotherapy-related toxicity. Traditionally, IPC is delivered by peritoneal lavage with a liquid solution. This form of delivery has limitations, including inhomogeneous intraperitoneal distribution and limited ability to penetrate tissues and metastatic nodules. An alternative mode of delivery is so-called pressurized intraperitoneal aerosol chemotherapy (PIPAC). Within this context, the present study sought to identify the pattern of spatial distribution of therapeutic solutions aerosolized into the peritoneal space using a single-port PIPAC device and ascertain whether the aerosolized method is superior to the traditional (liquid) mode of IPC delivery.

methodsAnalysis of the rate of intra-abdominal staining with aerosolized 2% silver nitrate in five porcine models.

resultsAssessment of differences in stain impregnation between the upper, middle, and lower abdomen did not reveal significant differences (p = 0.42). The median sum scores were 1 for the upper abdomen and 3 for the middle and lower abdomen.

conclusionsAerosolization does not reach all regions of the abdomen homogeneously. However, adequate exposure of the upper abdomen, mid-abdomen, and lower abdomen to chemotherapeutic agents can be achieved with PIPAC.

Indexed as

Peritoneal NeoplasmsAbdominal CavityAerosolsAnimalsAntineoplastic AgentsDrug TherapyEquipment DesignInjections, IntraperitonealPeritoneumSwineAerosolsAntineoplastic AgentsAerosolInnovationMedical devicePeritoneal carcinomatosisPressurePressurized intraperitoneal aerosol chemotherapy (PIPAC)

Identifiers

PMID31372889
OpenAlexW2966522986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.